Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib effectively treats severe alopecia areata and is safe.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

Tofacitinib helped a woman regrow hair with no major side effects.

Vitamin D might help treat some types of hair loss, but more research is needed.

Topical calcineurin inhibitors might be safer than steroids for scarring alopecia, but more research is needed.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

A boy with alopecia regrew hair using a vitamin D cream after other treatments failed.

Dutasteride is more effective than finasteride for hair growth, and sublingual apomorphine quickly improves Parkinson's symptoms.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Ciproterone acetate improves hair regrowth and acne in most female patients.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Serum calprotectin is not a reliable marker for alopecia areata activity.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Nanocrystals improve alopecia areata treatment by better targeting hair follicles.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Cyproterone acetate was effective in treating acne, hirsutism, and alopecia with few side effects.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Tofacitinib may help treat severe hair loss, but more research is needed.